表紙
市場調查報告書
商品編碼
982508

新型冠狀病毒感染(COVID-19):全球臨床試驗檢討 (2021年前期)

Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H2, 2021

出版日期: | 出版商: GlobalData | 英文 2992 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球新型冠狀病毒感染(COVID-19)的臨床試驗相關主要資料,主要國家的實驗數和平均登記數,地區,國家 (G7及E7)、階段,實驗現狀,端點現狀,及各贊助商類型的臨床試驗的範圍,有前途藥物相關資訊。

附註:報告特定的章節,可能會根據所顯示疾病的資料可用性和相關性而刪除或更改。

目錄

目錄

表格的清單

圖的清單

  • 報告指南
  • GlobalData的臨床試驗調查範圍
  • 臨床試驗:各地區
  • 臨床試驗數和平均登記數:各國
  • 在亞太地區中對臨床試驗有貢獻的前五國
  • 在歐洲中對臨床試驗有貢獻的前五國
  • 在北美中對臨床試驗有貢獻的前幾名的國家
  • 在中東、非洲中對臨床試驗有貢獻的前五國
  • 在中南美中對臨床試驗有貢獻的5個國家
  • G7各國的臨床試驗:感染疾病的臨床試驗中新型冠狀病毒感染(COVID-19)的比例
  • G7各國的臨床試驗:各階段
  • G7各國的臨床試驗:各臨床實驗狀態
  • E7各國的臨床試驗:感染疾病的臨床試驗中新型冠狀病毒感染(COVID-19)的比例
  • E7各國的臨床試驗:各階段
  • E7各國的臨床試驗:各臨床實驗狀態
  • 臨床試驗:各階段
  • 進行中的臨床試驗:各階段
  • 臨床試驗:各臨床實驗狀態
  • 臨床試驗:端點現狀
  • 一定期間內募集的實驗對象
  • 臨床試驗:各贊助商類型
  • 著名的贊助商
  • 新型冠狀病毒感染(COVID-19)參加治療藥物臨床實驗的主要企業
  • 有潛力的藥劑
  • 臨床試驗簡介的概述

附錄

  • 簡稱
  • 定義
  • 調查手法
  • 2次調查
  • 關於GlobalData
  • 諮詢方式
  • 來源
目錄
Product Code: GDHC6772CTIDB

GlobalData's clinical trial report, "Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H2, 2021" provides an overview of Coronavirus Disease 2019 (COVID-19) Clinical trials scenario. This report provides top line data relating to the clinical trials on Coronavirus Disease 2019 (COVID-19) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations 3012
  • Definitions 3012
  • Research Methodology 3013
  • Secondary Research 3013
  • About GlobalData 3014
  • Contact Us 3014
  • Source 3015

List of Tables

List of Tables

  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Region, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, North America, Top Countries, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2021*
  • Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, G7 Countries (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, E7 Countries (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Phase, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures

List of Figures

  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Region (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2021*
  • Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, G7 Countries (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, E7 Countries (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Phase (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
  • GlobalData Methodology